A recent study analyzing peripheral immune cells from patients with metabolic syndrome—a condition frequently overlapping with Long COVID—demonstrated a significant reduction in peroxisome proliferator-activated receptor alpha (PPARα) expression in eosinophils, which was inversely correlated with CD36 receptor levels [121]. Here, PPARA is linked to metabolic syndrome.